Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial, page-219

First 219 Last

Share
Profile

Follow
reon1

1,429 Posts.

455

11/11/23

17:34

Post #: 70848121
Share

Originally posted by Taureanbull: ↑

James, From memory the presentation covering the next Azer-cel trial was due to start in April 24. So by starting this week and reduced to 10 pax we should finish much earlier than previously predicted. The 13 hospitals and the enrolling Oncologist are all still in place. They should be already scouting for patients. They’ve known this is coming and also known the results so far have been outstanding.

So Azer-Cel could move very fast through the registrational trials to market.

So IMU will probably be fielding calls to BP sounding out their best options for selling and distributing AZER-Cel. I just can’t see PH recruiting a sales team here.

SOA deal within months is on the cards. ACAD who have the license for NEU’s drug started recruiting and building out their infrastructure at least 12 months in advance of FDA approval.

Monil Shah will be out now chasing his first commercial deal. This will come with a big upfront cheque. With a market size of US$2.5bn it will be a real prize for a BP. NEU’s drug only had and estimated market size of $500M. So it’s easy to understand just how much competition there will be amongst the Oncology focussed companies to get their hands on Azer-Cel.

Yesterday’s run up to .15 was well justified by this PS announcement. However all the traders dumped it back to .105 . But for those long term fundies who follow this stuff will know that a lot of value was added to IMU with this announcement.

Expand

Na was meant to start Q4 2023, so still on original schedule.

.

IMU Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
20 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Aussie futures fall on overall weak night in the US

AMI

First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia

Talking Australia's very competitive property landscape: Realty Talks

ABY

Adore Beauty FY24 revenues up 7.4% YoY to $196M

AI stocks: What to expect in 2024-25

There are more pages in this discussion • 24 more messages in this thread...

First 219 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.6¢		Change 0.001(1.82%)		Mkt cap ! $411.5M

Open	High	Low	Value	Volume
5.5¢	5.7¢	5.3¢	$731.7K	13.32M

Buyers (Bids)

No.	Vol.	Price($)
5	580359	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.7¢	686331	5

View Market Depth

No.	Vol.	Price($)
1	6634	0.061
4	537543	0.057
6	289810	0.056
15	1239101	0.055
10	727071	0.054

Price($)	Vol.	No.
0.057	533843	4
0.058	1056662	7
0.059	191714	3
0.060	1646398	15
0.061	791000	5

Last trade - 16.10pm 18/07/2024 (20 minute delay)

IMU (ASX) Chart

Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial, page-219

ASX Market Open: Aussie futures fall on overall weak night in the US

First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia

Talking Australia's very competitive property landscape: Realty Talks

Adore Beauty FY24 revenues up 7.4% YoY to $196M

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial, page-219

Top Stories

ASX Market Open: Aussie futures fall on overall weak night in the US

First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia

Talking Australia's very competitive property landscape: Realty Talks

Adore Beauty FY24 revenues up 7.4% YoY to $196M

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News